BTRC and diabetic kidney disease: Qiao and colleagues have shown that mTOR and Nrf2 also interact via the β-TrCP/Nrf2 pathway [151], wherein mTOR promotes Nrf2 nuclear translocation through inhibiting β-TrCP expression; this process is critical to the initiation and progression of diabetic nephropathy [151].